Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1993
11/23/1993US5264217 Method of increasing the total fat content of milk
11/23/1993US5264216 Treatment of bacterial infections
11/23/1993US5264207 Polymeric microspheres
11/23/1993US5264206 Nail lacquer with antimycotic activity, and a process for the preparation thereof
11/23/1993CA1324611C Process for the preparation of taxol
11/23/1993CA1324607C Dipyrazoles useful as bronchodilators
11/23/1993CA1324606C Thiopyranodipyrazoles
11/23/1993CA1324605C Derivatives of 1-arylsulfonyl-2-pyrrolidionone, process for their preparation and novel intermediates thus obtained, their applications as medecines, and compositions containing them
11/23/1993CA1324576C Process for making a spray-dried, directly- compressible vitamin powder comprising unhydrolyzed gelatin
11/23/1993CA1324527C Lipidic emulsion for parenteral or enteral use
11/22/1993CA2091709A1 Method for inhibiting aromatase
11/21/1993CA2096616A1 7beta-substituted-4-aza-5alpha-androstan-ones as 5alpha-reductase inhibitors
11/21/1993CA2096576A1 7beta-substituted-4-aza-5alpha-cholestan-ones as 5alpha-reductase inhibitors
11/21/1993CA2096196A1 Pharmaceutical compositions
11/21/1993CA2096152A1 Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
11/20/1993CA2096511A1 Selfadhesive matricial system for the transdermal sustained liberation of piribedil
11/20/1993CA2096475A1 Benzimidazole derivatives; process for their preparation and pharmaceutical compositions containing them
11/20/1993CA2068927A1 Treatment of cardiovascular disease associated with diabetes, uremia, gout and arthritis
11/19/1993CA2096406A1 Thiochromanic compounds, method of preparation thereof and pharmaceutical compositions containing them
11/19/1993CA2096394A1 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
11/19/1993CA2095279A1 Aryl and heteroaryl (phosphinylmethyl) phosphonate squalene synthetase inhibitors and method
11/18/1993EP0570294A1 2-Formylpyridine thiosemicarbazone derivatives, their preparation and their use as antitumor agents
11/18/1993EP0570263A1 New alkene carboxylic acid derivatives, process for their preparation and pharmaceutic compositions containing them
11/18/1993EP0570245A2 Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
11/18/1993EP0570232A2 Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol
11/18/1993EP0570230A1 External preparation for skin
11/18/1993EP0570112A1 Cycloalkane derivatives
11/18/1993EP0570091A1 Anthraquinone derivatives, process for their preparation and their use as medicaments
11/18/1993EP0570022A2 Chelants possessing ortho ligating functionality and complexes thereof
11/18/1993EP0569811A1 Dithiolanylglycine containing HIV-protease inhibitors of the hydroxyethylene isostere type
11/18/1993EP0569802A1 Arylacetamides
11/18/1993EP0569795A1 Sulphonylbenzyl substituted benzo- and pyridopyridones
11/18/1993EP0569794A1 Biphenylmethyl-substituted pyridones useful as angiotensin II receptor antagonists.
11/18/1993EP0569598A1 Benzoxazinone derivative
11/18/1993EP0569575A1 Trisubstituted pyrrole derivatives having antifungine activity, a process for their preparation and related pharmaceutical compositions
11/18/1993EP0569564A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
11/18/1993EP0569533A1 Aryl macrocyclic compositions for treating viral infections
11/18/1993EP0569507A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy
11/18/1993EP0569493A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
11/18/1993EP0569491A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/18/1993EP0569479A1 Long-term delivery device including hydrophobic loading dose
11/18/1993EP0569457A1 Use of thiazolo- 2,3-a]isoindole derivatives as antiviral medicaments and novel thiazolo- 2,3-a]isoindole derivatives.
11/18/1993EP0569415A1 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
11/18/1993EP0569414A1 Benzamides
11/18/1993EP0569409A1 Amide derivatives and their therapeutic use
11/18/1993EP0569396A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion
11/18/1993EP0456670B1 FAT EMULSION CONTAINING $g(v)-3 FATTY ACIDS FOR INTRAPERITONEAL APPLICATION, ITS PRODUCTION AND USE
11/18/1993EP0439549B1 Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization
11/18/1993EP0328524B1 Transdermal fertility control system and process
11/18/1993DE4310935A1 Microemulsions esp. for diagnosis and therapy of tumours - are protein-free and contain hydrophobic component of cholesterol ester and phospholipid(s) and opt. tri:glyceride(S) and/or free cholesterol
11/18/1993DE4216004A1 Use of competitive progesterone antagonists - to inhibit development of endometrial glands essential for implantation of eggs in the uterus
11/18/1993DE4216003A1 New 11,19-, phenylene-17-hydroxy-4-androsten-3-one derivs. - are implantation inhibitors which have little or no effect on ovulation
11/17/1993EP0641217A4 Amylase-electrolyte oral rehydration method and apparatus.
11/17/1993CN1078473A "Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof"
11/17/1993CN1078472A Preparation method for monoacetyl spiramycin
11/17/1993CN1078471A Pharmaceuticals
11/17/1993CN1078470A Optionally substituted pyrido |2,3-d¨ pyrimidine-2,4(1H,3H)-diones and pyrido |2,3-d¨ pyrimidine-2(1H,3H)-ones
11/17/1993CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo |2,3-c¨ pyridin-7-one derivatives
11/17/1993CN1078468A Sulphonylbenzyl-substituted pyridones
11/17/1993CN1078466A Benzoxazinone and benzothiazinone derivatives endowed with cardiovscular activity
11/17/1993CN1078400A Method for reducing side effects of a drug
11/17/1993CN1078399A Health-care medicament for rehabilitating function
11/17/1993CN1078388A Treatment of disease employing hyuluronic acid and NSAIDS
11/17/1993CN1078387A Preparation method for beriberi powder
11/17/1993CN1022755C Process for preparation of N-imidazolyl-and N-imidazolyl methyl-derivatives of substituted bicyclic compounds
11/17/1993CN1022754C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method
11/17/1993CA2096327A1 Salts of 3-(cis-2,6-dimethylpiperidino)sydnone imine
11/16/1993US5262568 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
11/16/1993US5262565 Naphthalene derivatives
11/16/1993US5262564 Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
11/16/1993US5262440 Antitumor compositions and methods of treatment
11/16/1993US5262439 Soluble analogs of probucol
11/16/1993US5262437 Homo-prostaglandin derivatives as ocular hypotensives
11/16/1993US5262430 Antidiabetic agent lowers blood glucose in mammals in type 2 non insulin dependent diabetes
11/16/1993US5262429 Aryl-quinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid compounds which have useful pharmaceutical utility
11/16/1993US5262428 Biologically active tropane derivatives
11/16/1993US5262427 3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions
11/16/1993US5262426 Treatment of cardiovascular disorders, antiinflammatory agents
11/16/1993US5262425 α-mannosidase inhibitors
11/16/1993US5262423 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
11/16/1993US5262421 Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis
11/16/1993US5262419 Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
11/16/1993US5262418 Laxatives, gastrointestinal disorders
11/16/1993US5262415 Aminopyridine compounds
11/16/1993US5262413 Use of isoxazolin-3-one derivatives as antidepressants
11/16/1993US5262412 Substituted pyrazoles, compositions and use
11/16/1993US5262411 Isocephem derivatives, and antimicrobial composition containing the derivatives
11/16/1993US5262410 3-heterocyclic thiomethyl cephalosporins
11/16/1993US5262409 Binary tumor therapy
11/16/1993US5262408 Low estrogen oral contraceptives
11/16/1993US5262407 Use of salicylic derivatives for the treatment of skin aging
11/16/1993US5262406 Preventing transfer of infection from mother to fetus, treating newborns
11/16/1993US5262405 Method of improving bronchial mucus transport
11/16/1993US5262404 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
11/16/1993US5262402 Process for preparing pyrimidinetrione derivatives
11/16/1993US5262400 Antiparasitic and anthelmintic
11/16/1993US5262180 Method for treating acute alkali exposure with carbon dioxide
11/16/1993US5262179 Masking unpleasant taste by mixing alkali metal bicarbonate, monohydrogen phosphate or tribasic citrate
11/16/1993US5262174 Administering lithnium salt with one of cytarabine or idoxyridine
11/16/1993US5262173 Pulsatile once-a-day delivery systems for minocycline
1 ... 7151 7152 7153 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 7167 7168 7169 7170 7171 ... 7860